MCIM
REGN icon

Meadow Creek Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Meadow Creek Investment Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$2.34M Sell
8,428
-112
-1% -$33.1K 0.05% 306
2019
Q2 		$2.67M Sell
8,540
-7,056
-45% -$2.35M 0.05% 290
2019
Q1 		$6.4M Buy
15,596
+10,500
+206% +$4.32M 0.13% 147
2018
Q4 		$1.9M Buy
5,096
+1,372
+37% +$502K 0.04% 315
2018
Q3 		$1.5M Buy
3,724
+840
+29% +$320K 0.03% 371
2018
Q2 		$995K Buy
2,884
+56
+2% +$17.5K 0.02% 436
2018
Q1 		$974K Sell
2,828
-476
-14% -$166K 0.02% 435
2017
Q4 		$1.24M Buy
3,304
+1,540
+87% +$624K 0.03% 407
2017
Q3 		$789K Sell
1,764
-84
-5% -$40K 0.02% 481
2017
Q2 		$908K Sell
1,848
-196
-10% -$85.8K 0.02% 434
2017
Q1 		$792K Sell
2,044
-28
-1% -$10.4K 0.02% 437
2016
Q4 		$760K Buy
+2,072
New +$788K 0.02% 424

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Meadow Creek Investment Management's REGN Position: Q3 2019 in Review

Meadow Creek Investment Management reduced its Regeneron Pharmaceuticals (REGN) stake by 1.3% in Q3 2019, selling an estimated $33.1K and leaving 8,428 shares worth $2.34M. The position accounts for 0.05% of the portfolio, ranked #306.

Meadow Creek Investment Management first reported a position in REGN in Q4 2016 and has held it in 12 quarters since. The position peaked at $6.4M in Q1 2019. 633 funds tracked by Wall St. Rank hold REGN as of Q3 2019.

  • Meadow Creek Investment Management held 8,428 shares of Regeneron Pharmaceuticals worth $2.34M as of Q3 2019.
  • Meadow Creek Investment Management sold 112 Regeneron Pharmaceuticals shares in Q3 2019, an estimated $33.1K.
  • Regeneron Pharmaceuticals made up 0.05% of Meadow Creek Investment Management's portfolio in Q3 2019, its #306 holding.
  • Meadow Creek Investment Management first reported a position in Regeneron Pharmaceuticals in Q4 2016 and has held it in 12 quarters since.
  • Meadow Creek Investment Management's Regeneron Pharmaceuticals position peaked at $6.4M in Q1 2019.
  • 633 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2019.

Based on Meadow Creek Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.